Overview

Location [1]
7q36.1
Protein [2]
Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3
Synonyms [1]
cnt-g3, AGAP-3, CRAG, CENTG3, MRIP-1

AGAP3 is altered in 0.06% of all cancers with colon adenocarcinoma, low-grade glioma, NOS, pancreatic adenocarcinoma, pilocytic astrocytoma, and thyroid gland papillary carcinoma having the greatest prevalence of alterations [3].

AGAP3 GENIE Cases - Top Diseases

The most common alteration in AGAP3 is AGAP3-BRAF Fusion (0.06%) [3].

AGAP3 GENIE Cases - Top Alterations

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.